Reaction
Anterior Chamber Cell reporting signals
As of the last recalculation, Anterior Chamber Cell appears in 711 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is AFLIBERCEPT (PRR 225.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Aflibercept | 180 | 225.8 | 227.1 |
| Prednisolone Acetate | 36 | 107.2 | 107.6 |
| Faricimab | 26 | 97.4 | 97.8 |
| Moxifloxacin Hydrochloride | 54 | 84.3 | 84.5 |
| Ranibizumab | 53 | 63.1 | 63.2 |
| Moxifloxacin | 20 | 42.7 | 42.8 |
| Timolol | 8 | 19.6 | 19.6 |
| Dorzolamide Hydrochloride And Timolol Maleate | 5 | 18.6 | 18.7 |
| Brimonidine Tartrate | 9 | 15.0 | 15.0 |
| Travoprost | 3 | 10.2 | 10.2 |
| Ranolazine | 3 | 8.4 | 8.4 |